Stay updated on Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The Locations section now includes a New York site, replacing the previous 'New York Locations' label. The page revision shows v3.3.3 and the HHS Vulnerability Disclosure link has been removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:22:53.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.3.1 to v3.3.2; no user-facing content or functionality appears affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:40:29.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not be about the study; updated the revision reference to v3.3.1 (replacing v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-24T14:49:12.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Deleted the government funding/operating status notice from the page. The core study details remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T06:55:37.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The screenshots appear to reflect only layout and formatting updates with no changes to the core study content (eligibility criteria, locations, interventions, or primary/secondary outcomes). No new or altered critical information that would affect a participant's decision to join or a site's participation has been observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:20:14.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:11:50.000Z thumbnail image

Stay in the know with updates to Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.